| First Author | Czarnek M | Year | 2020 |
| Journal | Mol Neurobiol | Volume | 57 |
| Issue | 4 | Pages | 1799-1813 |
| PubMed ID | 31838721 | Mgi Jnum | J:319902 |
| Mgi Id | MGI:6708483 | Doi | 10.1007/s12035-019-01846-9 |
| Citation | Czarnek M, et al. (2020) Proteolytic Processing of Neuregulin 2. Mol Neurobiol 57(4):1799-1813 |
| abstractText | Neuregulin 2 (NRG2) belongs to the EGF family of growth factors. Most of this family members require proteolytic cleavage to liberate their ectodomains capable of binding and activating their cognate ErbB receptors. To date, most of the studies investigating proteolytic processing of neuregulins focused on NRG1, which was shown to undergo ectodomain shedding by several ADAM proteases and BACE1 and the remaining fragment was further cleaved by gamma-secretase. Recently, NRG2 attracted more attention due to its role in the neurogenesis and modulation of behaviors associated with psychiatric disorders. In this study, we used genetic engineering methods to identify proteases involved in proteolytic processing of murine NRG2. Using non-neuronal cell lines as well as cultures of primary hippocampal neurons, we demonstrated that the major proteases responsible for releasing NRG2 ectodomain are ADAM10 and BACE2. Co-expression of NRG2 and BACE2 in neurons of certain brain structures including medulla oblongata and cerebellar deep nuclei was confirmed via immunohistochemical staining. The cleavage of NRG2 by ADAM10 or BACE2 generates a C-terminal fragment that serves as a substrate for gamma-secretase. We also showed that murine NRG2 is subject to post-translational modifications, substantial glycosylation of its extracellular part, and phosphorylation of the cytoplasmic tail. |
